Tyrosine Kinase-Dependent Release of an Adenovirus Preterminal Protein Complex from the Nuclear Matrix by Angeletti, Peter C. & Engler, Jeffrey A.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Virology Papers Virology, Nebraska Center for 
May 1996 
Tyrosine Kinase-Dependent Release of an Adenovirus Preterminal 
Protein Complex from the Nuclear Matrix 
Peter C. Angeletti 
University of Nebraska-Lincoln, pangeletti2@unl.edu 
Jeffrey A. Engler 
University of Alabama at Birmingham 
Follow this and additional works at: https://digitalcommons.unl.edu/virologypub 
 Part of the Virology Commons 
Angeletti, Peter C. and Engler, Jeffrey A., "Tyrosine Kinase-Dependent Release of an Adenovirus 
Preterminal Protein Complex from the Nuclear Matrix" (1996). Virology Papers. 28. 
https://digitalcommons.unl.edu/virologypub/28 
This Article is brought to you for free and open access by the Virology, Nebraska Center for at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Virology Papers by an 
authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
JOURNAL OF VIROLOGY, May 1996, p. 3060–3067 Vol. 70, No. 5
0022-538X/96/$04.0010
Copyright q 1996, American Society for Microbiology
Tyrosine Kinase-Dependent Release of an Adenovirus Preterminal
Protein Complex from the Nuclear Matrix
PETER C. ANGELETTI AND JEFFREY A. ENGLER*
Department of Biochemistry and Molecular Genetics, Schools of Medicine and Dentistry,
University of Alabama at Birmingham, Birmingham, Alabama 35294-0005
Received 14 September 1995/Accepted 12 February 1996
Adenovirus (Ad) replicative complexes form at discrete sites on the nuclear matrix (NM) through the
interaction of Ad preterminal protein (pTP). The NM is a highly salt-resistant fibrillar network which is known
to anchor transcription, mRNA splicing, and DNA replication complexes. Incubation of rATP with NM to
which pTP was bound caused the release of pTP as a pTP-NM complex with a size of 220 to 230 kDa; incubation
with 5* adenylylimidodiphosphate (rAMP-PNP) showed no significant release, indicating that rATP hydrolysis
was required. With NM extracts, it was shown that a pTP-NM complex which was capable of binding Ad origin
DNA could be reconstituted in vitro. A number of high-molecular-weight NM proteins ranging in size from 120
to 200 kDa were identified on Far Western blots for their ability to bind pTP. rATP-dependent release of pTP
from the NM was inhibited in a dose-dependent fashion by the addition of tyrosine kinase inhibitors, such as
quercetin, methyl-2,5-dihydroxycinnamate, or genistein. NM-mediated phosphorylation of a poly(Glu, Tyr)
substrate was also significantly abrogated by the addition of these compounds. rATP-dependent release of Ad
DNA termini bound to the NM via pTP was also blocked by the addition of these inhibitors. These results
indicate that a tyrosine kinase mechanism controls the release of pTP from its binding sites on the NM. These
data support the concept that phosphorylation may play a key role in the modulation of pTP binding sites on
the NM.
Initiation of adenovirus (Ad) DNA replication involves a
protein-priming mechanism which requires the interaction of
three viral proteins and two host proteins with the origin (14,
15, 53). The Ad DNA polymerase and the precursor to the
terminal protein (pTP) form a heterodimer which specifically
binds to the origins found at each end of the linear DNA
genome. A dCMP residue then becomes covalently linked to
pTP through the serine at position 580 in the protein. This
nucleotide provides a 39 hydroxyl group to begin synthesis of a
daughter Ad DNA strand. Nuclear factors I and III, which
enhance initiation, are cellular proteins that bind to the Ad
origin between bases 18 to 40 and 40 to 52, respectively (46).
Ad DNA-binding protein stabilizes the single-stranded regions
of the origin during synthesis. It has become clear that pTP
mediates attachment of the Ad origin to specific sites on the
nuclear matrix (NM) (7, 49, 60). Replication studies done by
Fredman and colleagues (23, 24) showed that pTP mutants
(p233, p340, and p344) were wild type in in vitro replication
assays but were defective for replication in vivo. These results
pointed to a critical role for pTP, potentially in the formation
of replicative complexes at the NM. Other studies report that
the pTP association with the NM is also important for tran-
scription of the early genes (49). We were therefore interested
in understanding the nature of the interaction between pTP
and the NM.
The NM is a complex protein network in the nucleus which
can be revealed by DNase treatment followed by high-salt or
lithium-3,5-diiodosalicilate extraction (3, 4, 36). The nuclear
infrastructure consists of internal core filaments, lamina, and
integral membrane proteins which, together, provide the struc-
tural integrity of the nucleus. Apart from providing structural
support, the NM appears to define discrete regions for enzyme
activity (2). Virtually all genomic DNA is organized into su-
percoiled loops which are attached to the NM via matrix at-
tachment regions. It is thought that matrix attachment regions
coincide with origins of replication (9). The NM is involved in
many important cellular activities, such as transcription, mRNA
splicing, mRNA transport, chromatin organization, and DNA
replication (6, 28, 35, 49). Therefore, it is not surprising that
sites of Ad replication and transcription are discretely localized
to foci in the nuclear substructure (11, 37). The interaction of
Ad pTP with the NMmay link these cellular processes with the
viral life cycle.
The integrity and function of the NM is modulated by post-
translational modifications. Changes in the activity and mor-
phology of the nucleus throughout the cell cycle require the
NM to be implicitly dynamic. There is ample evidence that NM
proteins are the targets of posttranslational activities, such as
phosphorylation, methylation, isoprenylation, proteolysis, and
perhaps glycosylation (22, 27, 34, 35). The well-characterized
NM proteins, lamins, serve as examples of most of these pro-
cesses. Phosphorylation appears to be a major control mecha-
nism of the NM. Lamin proteins contain two p34cdc2 phosphor-
ylation sites which play a direct role in polymer dynamics (39).
Nuclear disassembly is driven by the hyperphosphorylation of
lamin filaments (21). Dessev et al. (17) described a protein
kinase activity which is associated with the NM and which is
directed toward lamin and inhibitable by quercetin. In these
studies, solubilization of lamin complexes from the nucleus was
shown to be dependent on an endogenous kinase activity (16).
Similarly, the phosphorylation state of Rb appears to control
its binding to an NM component (p84) (18). Rb has also been
shown to directly bind lamin A and C (33). There is also
evidence of both casein kinase II and tyrosine kinase activity
associated with the NM (40, 54). We reasoned that these NM
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kinase activities may play a role in controlling the binding of
pTP-NM complexes or pTP itself to the NM in a manner
similar to that for other NM proteins. Here, we report the
presence of a tyrosine kinase activity which is associated with
the human cell NM and which controls the release of prerep-
licative pTP complexes from the NM.
MATERIALS AND METHODS
Cell lines, viruses, and antibodies.HeLa cells were used for the analysis of the
pTP-NM interaction. Cells were grown in monolayer cultures at 378C in Dul-
becco’s modified Eagle’s medium supplemented with 5% fetal bovine serum. Ad
infections were done at a multiplicity of infection of 10. Virus was allowed to bind
to the cells for 1 h in 4 ml of Dulbecco’s modified Eagle’s medium without fetal
bovine serum. The infected cells were washed with phosphate-buffered saline
(PBS) and then given 8 ml of Dulbecco’s modified Eagle’s medium with 5% fetal
bovine serum. The cells were harvested at 15 h postinfection (p.i.). High-level
expression of pTP was achieved by utilizing a recombinant vaccinia virus con-
taining Ad type 5 pTP (vvpTP1; 23) under the control of a T7 promoter. A
second virus containing the T7 RNA polymerase (vvT7; 25) was coinfected into
the cells. The cells were infected at a multiplicity of infection of 10 for each virus
and harvested at 20 h p.i.
A rabbit polyclonal antibody (3-1A) recognizing the pTP was raised to a
carboxy-terminal peptide (PEPPLPPGARPRRRC) which was conjugated to
keyhole limpet hemocyanin. The 3-1A antibody was used at room temperature
for developing Western blots (immunoblots) at a dilution of 1:1,000. The poly-
clonal antibody used for the detection of human lamin proteins was the generous
gift of Robert Goldman (Northwestern University School of Medicine). A goat
anti-rabbit immunoglobulin G to which alkaline phosphatase was conjugated
(Southern Biotechnology Associates, Birmingham, Ala.) was used as the second-
ary antibody. A monoclonal antibody (MAb) (IB6A8) was raised to purified pTP
and was used for the supershift of gel-shifted pTP-DNA complexes.
Preparation of NM. The protocol used for the preparation of NM was similar
to that described by Mirkovitch et al. (36). Uninfected or vvpTP1- or Ad-infected
HeLa cells were fractionated and nuclei were recovered by the techniques de-
scribed by Challberg and Kelly (13). Typically, five to seven plates (100-mm
diameter) of confluent cells were harvested. Isolated nuclei were resuspended in
500 ml of digestion buffer (20 mM Tris-HCl [pH 7.4], 0.05 mM spermine, 0.125
mM spermidine, 20 mM KCl, 70 mM NaCl, 10 mM MgCl2) with 1 mM phenyl-
methylsulfonyl fluoride (PMSF) and subjected to DNase I digestion for 10 min
at room temperature at a final concentration of 0.1 mg/ml (36). For Southern blot
analysis of Ad DNA ends, Ad-infected nuclei were incubated with HindIII
enzyme at a concentration of 1 U/ml in the appropriate buffer for 2 to 3 h at 378C.
The nuclei were then resuspended in digestion buffer with 0.1% digitonin and
incubated at room temperature for 5 to 10 min. The nuclear pellet was recovered
by centrifugation at 10,000 3 g in a microcentrifuge. The nuclear material was
then extracted with high-salt buffer (2 M NaCl, 20 mM HEPES [N-2-hydroxy-
ethylpiperazine-N9-2-ethanesulfonic acid] [pH 7.4], 20 mM EDTA) for 5 min on
ice. The resultant nuclear pellet was washed several times in digestion buffer and
finally resuspended in 100 ml of buffer with 1 mM PMSF. Protein concentrations
of the NM preparations were determined by the method of Bradford (Bio-Rad,
Richmond, Calif.) (10). Generally, concentrations of 5 to 10 mg/ml were achieved.
Preparation of cytoplasmic extracts and nuclear matrix extracts (NME).One-
hundred-millimeter-diameter plates of HeLa cells which were coinfected with
the vvpTP1 and vvT7 viruses as previously described were resuspended in hypo-
tonic buffer (20 mM HEPES [pH 7.5], 5 mM KCl, 0.5 mM MgCl2, 0.5 mM
dithiothreitol [DTT]) and allowed to swell on ice for 15 min. The cells were lysed by
10 strokes of a tight-clearance Dounce homogenizer. The nuclear material was
pelleted at 2,0003 g for 10 min at 48C in a microcentrifuge. The cytoplasmic
supernatant was recovered and clarified by an additional centrifugation at
15,000 3 g for 4 min (13).
NME was prepared by either an rATP incubation or an 8 M urea extraction of
NM. The development of the rATP NME was based on previous work which
showed that phosphorylation of many NM proteins caused their solubilization
(16, 21, 22, 26). The buffer (30 mM NaCl, 15 mM Tris-HCl, [pH 7.0], 3 mM
MgCl2, and 1 mM DTT) (26) was combined with 1 U of creatine kinase per ml
and 12.5 mM creatine phosphate for rATP regeneration (49). b-Glycerophos-
phate was included to reduce phosphatase activity (52). Typically, 500 mg of NM
was incubated in the phosphorylation buffer with 3 mM rATP for 1 h at 258C.
The supernatant was then recovered by centrifugation in a microcentrifuge. The
protein concentrations, excluding that of creatine kinase, were usually 0.5 to
1 mg/ml. The 8 M urea NME was prepared in a manner similar to that described
by Fey and Penman (20). The nuclear pellet was washed several times in diges-
tion buffer containing 1 mM PMSF. High-salt NM was then prepared by the
previously mentioned techniques. The NM pellet was extracted with a threefold-
volume equivalent of disassembly buffer (8 M urea, 20 mM MES [morpho-
lineethanesulfonic acid] [pH 6.6], 1 mM EDTA, 0.1 mM MgCl2, 1% b-mercap-
toethanol, 1 mM PMSF). The supernatant was collected by centrifugation at
15,000 3 g for 4 min. The NME was then step dialyzed for 2 h in 1,000 volumes
of the same buffer with urea at 4, then 2, 1, and 0.1 M successively at 48C. The
final dialysis was in 1,000 volumes of buffer B [20 mM NaCl, 20 mM HEPES (pH
7.5), 5 mM MgCl2, 1 mM DTT, and 1 mM 4-(2-aminoethyl)benzenesulfonyl
fluoride (AEBSF; Calbiochem, La Jolla, Calif.)] overnight at 48C. To remove the
fluffy white precipitate that contained NM intermediate filament protein and
that formed during dialysis, the NME was again clarified by centrifugation at
15,000 3 g for 5 min. The NME protein concentrations were usually on the order
of 1 mg/ml.
Labeling of pTP. One-hundred-millimeter-diameter plates of HeLa cells coin-
fected with vvpTP1 and vvT7 were incubated for 30 min in 4 ml of methionine
minus Dulbecco’s modified Eagle’s medium (GIBCO BRL, Gaithersburg, Md.)
at 17 h p.i. Labeling of pTP was carried out for 2 h in the presence of 0.05 mCi
of 35S-Trans label (Amersham, Arlington Heights, Ill.) per ml in a total volume
of 4 ml. Specific labeling of pTP was possible because of the fact that vaccinia
virus inhibits host cell protein synthesis and that pTP contains 20 methionine
residues. The infected cells were harvested and pTP-NM was prepared as de-
scribed above.
Release of a pTP-NM complex. Release of pTP complexes was assayed. Fifty
micrograms of pTP-NM was incubated with 3 mM rATP in 30 ml of phosphor-
ylation buffer containing 1 mMDTT for 1 h at room temperature in the presence
of 1 mM PMSF. Protein released to the supernatant was recovered from the
reaction mixture by centrifugation at 15,000 3 g for 5 min. The supernatant was
resuspended in Laemmli buffer with either 2 or 0.1% sodium dodecyl sulfate
(SDS) (31). In order to analyze the native pTP complexes, the samples were
either boiled or not and loaded onto an 8% polyacrylamide gel. The protein was
transferred to nitrocellulose and probed with the anti-pTP or anti-lamin anti-
bodies.
pTP Far Western assay. The pTP Far Western experiment was adapted from
the protocol described by Carriere et al. (12). Twenty micrograms of whole NM,
rATP NME, or 8 M urea NME was heated in Laemmli denaturing buffer and
electrophoresed on a 10% polyacrylamide gel. The protein was then transferred
to nitrocellulose and blocked against 5% dry milk protein in PBS. The blot was
gently rocked at 258C overnight with 1 mg of cytoplasmic extract from cells
infected with vvpTP1 and vvT7 in 5 ml of PBS with 1% dry milk protein and
2 mM AEBSF. The blot was rinsed with PBS for 10 min at room temperature.
The subsequent development of the blot was the same as that for a Western blot.
NM tyrosine kinase activity assay. Fifty micrograms of pTP-NM was incu-
bated in phosphorylation buffer with or without 10 mg of the tyrosine kinase
substrate poly(Glu, Tyr) at 4:1 (Sigma, St. Louis, Mo.) and 5 mCi of [g-32P]ATP
(47). b-Glycerophosphate at 50 mM was included in the reactions to inhibit
endogenous phosphatase activity (54). Incubations were done with or without
quercetin (296 mM), methyl-2,5-dihydroxycinnamate (2,5-MeC) (52 mM), or
genistein (130 mM) in the presence of 1 U of creatine kinase per ml and 12.5 mM
creatine phosphate (47, 51, 52). These concentrations of each inhibitor were
those which had shown maximal inhibition of pTP release (see Fig. 5). The
reaction was carried out for 1 h at 258C. The supernatants were subjected to
electrophoresis on a 0.1% SDS–8% polyacrylamide gel and then blotted to
nitrocellulose and probed for the presence of pTP. Radioactive counts incorpo-
rated into the test substrate because of phosphorylation by the putative tyrosine
kinase were visualized and quantitated with a PhosphorImager model 400E
(Molecular Dynamics, Sunnyvale, Calif.).
rATP-dependent release of pTP from NM. 35S-labeled pTP bound to NM was
prepared from HeLa cells programmed with vvpTP1. The pTP-NM was then
incubated in phosphorylation buffer and b-glycerophosphate with 3 mM rATP or
59 adenylylimidodiphosphate (rAMP-PNP) in the presence of an rATP regen-
erating system for 1 h at 258C. The rATP incubations were done in the presence
of increasing concentrations of quercetin, 2,5-MeC, or genistein. Supernatants
were collected and subjected to electrophoresis on an 8% polyacrylamide gel
containing 0.1% SDS. The gel was then vacuum dried. The release of 35S-labeled
pTP from the NM was visualized and directly quantitated with a PhosphorImager
(Molecular Dynamics). In all cases, a single radioactively labeled 80-kDa band
which was confirmed to be pTP by Western blot was released (data not shown).
The quantitation of the release of unlabeled pTP with Western blots developed
with a biotinylated secondary antibody and 35S-labeled streptavidin gave com-
parable results (data not shown). We also found that 2 M NaCl- or lithium-3,5-
diiodosalicilate-extracted NM gave similar results for quantitative pTP release
(data not shown). For the purpose of quantitation, triplicate or quadruplicate
samples for each concentration of inhibitor were averaged, standard deviations
were calculated, and the data were plotted with Cricket Graph III (Computer
Associates International, Inc., Islandia, N.Y.).
Southern blot analysis of rATP-released Ad DNA termini. HeLa cells infected
with Ad type 5 at a multiplicity of infection of 10 were harvested at 15 h p.i. The
nuclei were recovered and subjected to HindIII digestion for 2 to 3 h. High-salt
NM was then prepared. Fifty micrograms of Ad-NM was incubated in phosphor-
ylation buffer in the presence of 3 mM rATP or rAMP-PNP and an rATP
regeneration system. Duplicate rATP-containing samples were incubated with
concentrations of the tyrosine kinase inhibitors which were maximally inhibitory
to pTP release (see Fig. 5). The reactions were carried out at 258C for 1 h. To
ensure that the DNA fragments were not being nonspecifically trapped, the
Ad-infected NM was washed twice with the same 2 M NaCl buffer used to
prepare the NM (49). The recovered supernatants and pellets were then digested
with proteinase K (10 mg/ml) for 3 h at 458C. The DNA samples were heated to
1008C for 5 min and snap cooled on ice. The DNA was then dot blotted to two
nitrocellulose filters with a vacuum transfer apparatus (1). The blots were then
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carefully placed on a Whatman 3MM filter soaked in denaturing solution (1.5 M
NaCl, 0.5 M NaOH) for 10 min. The blots were laid on top of another Whatman
3MM filter soaked in neutralization solution (1.5 M NaCl, 0.5 M Tris-HCl [pH
7.0]) for 5 min (1). The DNA was then cross-linked to the nitrocellulose with a
UV Stratalinker 1800 set on automatic mode (Stratagene). The blots were then
rinsed with 23 SSC (13 SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and
put into hybridization bags along with an appropriate amount of prehybridization
solution (53 SSC, 53 Denhardt’s solution, 0.1% SDS, 0.1 mg of salmon sperm
DNA per ml, 1 mM EDTA, 0.01 M sodium phosphate) for 2 h at 708C. Two
oligonucleotides were chosen for the analysis of the Ad DNA ends: 823-842 (59-T
TCTCCGGAGCCGCCTCACC-39, adjacent to E1a) and 35,683-35,702 (59-
CCCAGAAAACCGCACGCGAA-39, adjacent to E4). Twenty picomoles of each
probe was end labeled with 20 mCi of [g-32P]ATP by using 10 U of T4 polynu-
cleotide kinase (Pharmacia, Piscataway, N.J.) The reaction was carried out for 30
min at 378C and stopped by heat treatment at 1008C for 5 min. Each of the
labeled oligonucleotides was added to separate plastic bags containing hybrid-
ization solutions and the identical nitrocellulose blots. The blots were heated to
708C for 10 min and then were allowed to cool slowly in a water-filled container
overnight with shaking. The blots were then washed thoroughly with two changes
of 23 SSC for 1 h at 258C and visualized and quantitated with a PhosphorImager
(Molecular Dynamics) (1, 23).
pTP-NM gel shift assay. Gel shift assays were performed with a double-
stranded oligonucleotide spanning the first 18 bp of the Ad type 5 origin of
replication. The top (59-CATCATCAATAATATACC-39) and bottom (59-GGT
ATATTATTGATGATG-39) strands were synthesized on an Applied Biosystems
394 DNA synthesizer. The procedure for pTP gel shift was similar to that of
Kusukawa et al. (30). Twenty picomoles of the top strand was 59 end labeled with
T4 polynucleotide kinase (Pharmacia) and [g-32P]ATP (20 mCi). The unlabeled
bottom strand was annealed in a 10-fold excess to the top strand. The annealing
was carried out at 708C for 5 min, and it was followed by a slow cool to room
temperature (29). The double-stranded DNA (dsDNA) oligonucleotide was then
desalted with an S-300 microspin column (Pharmacia). The final volume was
adjusted to give a concentration of 1 pmol/ml of the dsDNA 18-mer. One
picomole of end-labeled dsDNA 18-mer was incubated with either no protein,
10 mg of HeLa cytoplasm, 10 mg of NME, or 10 mg of pTP extract from a vvpTP1
infection. Supershift was performed by the addition of 1 ml of purified anti-pTP
MAb to a reaction mixture with pTP and the oligonucleotide. Competition of
pTP from the radiolabeled probe was achieved by the addition of 300 pmol of
unlabeled dsDNA 18-mer. Experimental conditions contained either 5 mg of
rATP NME or 8 M urea NME incubated with 10 mg of pTP extract and the
dsDNA 18-mer. Reactions were carried out for 30 min at 258C in a total volume
of 30 ml containing 25 mM HEPES (pH 7.4), 20 mM KCl, 1 mM DTT, 0.1 mM
EDTA, and 1 mg of poly(dI)-poly(dC). The samples were then supplemented
with DNA gel loading buffer (0.025% bromphenol blue, 0.025% xylene cyanol,
and 20% Ficoll) and separated by electrophoresis on a 5% polyacrylamide gel
containing 0.1% SDS and 0.53 Tris-borate-EDTA buffer. The gel was vacuum
dried to Whatman 3MM paper with a gel dryer (Bio-Rad, Hercules, Calif.). The
gel-shifted bands were visualized with a PhosphorImager (Molecular Dynamics).
RESULTS
Previous work has shown that pTP binds tightly to the NM
through the course of infection (24, 49). However, there has
been little progress in the identification of the NM protein(s)
to which pTP binds or in the understanding of the mechanisms
which regulate this interaction. For this reason, we investigated
the factors that affect the binding of Ad DNA ends to the NM.
Release of Ad DNA ends from the NM requires rATP hy-
drolysis. While screening for reagents that released Ad DNA
ends or pTP proteins from the NM, we observed that added
rATP could release a sizeable fraction of the bound Ad DNA
(Fig. 1A). The release of Ad DNA termini in the presence of
3 mM rATP was measured by DNA dot blotting of the rATP-
released material probed with 32P-labeled oligonucleotides
specific for Ad DNA ends; the Ad end-specific counts were
quantitated on a PhosphorImager and expressed as a percent-
age of the total Ad DNA termini that was bound in high-salt-
extracted NM prior to treatment. The smaller amount of re-
lease observed in the absence of rATP might be attributed to
endogenous rATP that remained in the NM preparation. This
release of Ad DNA ends required rATP hydrolysis, as shown
by the lower release observed when NM from Ad-infected cells
was incubated with 3 mM rAMP-PNP.
To confirm this result, NM from cells infected with a vac-
cinia virus recombinant that expresses high levels of pTP and
that was labeled with [35S]methionine was extracted with high
NaCl and treated with rATP as described in Materials and
Methods. In this case, the amount of an 80-kDa 35S-labeled
pTP protein band released by this treatment was quantitated
on a PhosphorImager, and the amount of pTP released was
expressed as a percentage of the total pTP in the NM prior to
treatment; there were no other 35S-labeled proteins in this size
range released by rATP treatment. In this case, rATP-medi-
ated release was also detectable but at a lower level (1.5%)
compared with that of the total pTP protein present. The most
likely explanation for this difference is that at high levels of
vvpTP1 expression, the rATP-releasable pTP binding sites are
oversaturated and that the majority of the pTP protein binds
elsewhere in the NM, perhaps at lower-affinity sites that are
not capable of release with rATP. The higher percentage of
pTP release from NM in a normal Ad infection may reflect a
specific preference for binding of Ad DNA to the rATP re-
leasable sites. The nonhydrolyzable rATP analog (rAMP-PNP)
had virtually no effect on release of pTP from the NM. Taken
together, these results indicate that rATP hydrolysis is a pre-
requisite to release of pTP of Ad DNA termini.
rATP-dependent release of a pTP-NM complex. Superna-
tants from incubations of pTP-NM with 3 mM rATP were
separated by electrophoresis under fully denaturing conditions
(either 2 or 0.1% SDS with heating) or under low SDS condi-
tions without heating. Duplicate sets of samples were probed
with specific antibodies for the presence of pTP or nuclear
lamins A and C (Fig. 2). Under low SDS conditions (0.1%)
without heating, a complex with a size of approximately 220 to
230 kDa that was recognized by an anti-pTP antibody (3-1A)
was detected; this antibody did not cross-react with the control
HeLa cell NM protein. Since pTP has a molecular mass of 80
kDa, formation of a pTP complex with a size of 220 to 230 kDa
would suggest that the cellular component(s) of the complex
would total approximately 140 to 150 kDa. The pTP complex
FIG. 1. Release of pTP or pTP-bound Ad DNA termini from the NM re-
quires the hydrolysis of rATP. (A) Fifty micrograms of 35S-labeled pTP bound to
NM was incubated with either 3 mM rATP, 3 mM rAMP-PNP (a nonhydroliz-
able rATP analog), or buffer alone (no rATP). Supernatants were electropho-
resed on an 8% polyacrylamide gel. The gel was vacuum dried to Whatman 3MM
paper and pTP was visualized with a PhosphorImager (Molecular Dynamics).
Triplicate samples were prepared for each condition. (B) Release of Ad DNA
termini from the NM was analyzed by Southern blotting under conditions iden-
tical to those described for panel A. Supernatants were dotted to nitrocellulose
in triplicate and probed with the left-end oligonucleotide (823-842). Hybridiza-
tion was visualized with a PhosphorImager (Molecular Dynamics). In both
graphs, release was quantitated, averaged, and expressed as a percentage of the
total pTP or Ad DNA. Error bars show standard deviations.
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could be disrupted by boiling in 2% SDS Laemmli buffer,
indicating that the interaction may be noncovalent, although
the presence of a sulfhydryl bond between pTP and the puta-
tive cellular protein(s) cannot be ruled out. This pTP complex
could be recapitulated in vitro with 35S-labeled NME prepared
by either rATP incubation or 8 M urea extraction (data not
shown). Taken together, these experiments defined the pres-
ence of a soluble and stable pTP interaction with one or more
NM proteins.
Under identical conditions with the same extracts, com-
plexes of nuclear lamins could also be identified with an anti-
lamin antibody. The lamin complexes visualized were consis-
tent with themonomer, dimer, and tetramers observed byMoir et
al. (38). However, the lamin complexes did not comigrate with
the pTP complex, suggesting the lamins are not a direct com-
ponent of the observed high-molecular-weight (high-MW)
pTP complex.
pTP binds directly to high-MW NM proteins in vitro. A Far
Western blot was used to determine whether the NM proteins
released by rATP or by 8 M urea (and subsequently dialyzed to
remove urea, as described in Materials and Methods) con-
tained proteins capable of binding pTP (Fig. 3). NM was pre-
pared from uninfected HeLa cells, and 20 mg of whole NM and
rATP NME and 8 M urea NME were separated by electro-
phoresis and immobilized on a nitrocellulose filter. As ex-
pected, the anti-pTP antibody (3-1A) used to detect pTP in-
teractions with cellular proteins on this blot did not cross-react
with any bands on the left side of the blot, which was incubated
with HeLa cytoplasmic extract that lacked pTP. The right side
of the same blot was incubated with a cytoplasmic extract from
HeLa cells infected with the vaccinia virus that expressed pTP
(vvpTP1); when probed with the anti-pTP antibody, a number
of high-MW bands were detected. There was a doublet near
200 kDa which bound pTP. The darkest bands were at about
140 to 150 kDa. Two other lower-MW bands with sizes of 30
and,20 kDa seemed to be present in whole NM and not in the
extracts (data not shown). The fact that there were numerous
proteins which bound pTP may imply (i) that there is more
than one type of pTP binding site among the proteins that
constitute the NM, (ii) that the cellular protein to which pTP
binds is subject to partial proteolytic degradation (perhaps as a
consequence of extraction) and that pTP can bind to one or
more of these degradation products, or (iii) that all of these
proteins may be involved in a larger complex. The sizes of the
strongly reacting bands (140 to 150 kDa) would be consistent
with the size of the complex seen in Fig. 2.
A tyrosine kinase controls release of pTP from the NM. In
order to understand the dynamics of the pTP-binding protein,
we chose to determine the mechanism of the rATP-dependent
release of pTP. Dessev et al. (17) had previously observed that
quercetin inhibited an NM kinase activity. Using this observa-
tion as a starting point, we confirmed that our NM prepara-
FIG. 2. A 220- to 230-kDa pTP-NM complex is released from the NM upon
incubation with rATP. Each panel contains duplicate supernatant samples which
were separated by electrophoresis on the same gel. Each half of the resultant
Western blot was probed with either anti-pTP antibody (3-1A) (left) or anti-
lamin antibody (right), as indicated. Samples were loaded onto the gel either
under fully denaturing conditions (2 or 0.1% SDS Laemmli buffer with heating)
or under low SDS conditions (0.1% SDS without heating). Uninfected NM
(HeLa NM) was included as a control for anti-pTP antibody cross-reaction. The
arrows on the left indicate the 220- to 230-kDa pTP complex and the 80-kDa
pTP. The arrows on the right panel point to the detected lamin multimers. The
numbers on the left are kilodaltons.
FIG. 3. pTP binds directly to high-MW NM proteins in vitro. Twenty micro-
grams of HeLa NM, rATP NME, and 8 M urea (U) NME (each) was loaded in
duplicate and separated by electrophoresis on a 10% polyacrylamide gel con-
taining 0.1% SDS and transferred to nitrocellulose. The identical halves of the
blot were incubated either with uninfected HeLa cytoplasm (cyto) or with pTP
cytoplasmic extract from HeLa cells infected with a pTP-expressing recombinant
vaccinia virus (vvpTP1) as indicated. The blots were then developed for the
presence of pTP with the polyclonal anti-pTP (3-1A) antibody. The negative
control incubation (HeLa cyto) showed no background. The high-MW NM
bands which showed pTP binding activity are indicated by the arrows. The top
arrow shows a doublet near 200 kDa. The lower arrow indicates the group of
bands which center around 140 to 150 kDa. The numbers to the left of the blots
are kilodaltons.
FIG. 4. Tyrosine kinase inhibitors block NM-mediated phosphorylation of an
exogenous poly(Glu, Tyr) substrate. Fifty micrograms of pTP-NM was incubated
with 5 mCi of [g-32P]ATP, 10 mg of a tyrosine kinase substrate, and the tyrosine
kinase inhibitors as described. The supernatants from each reaction were recov-
ered and separated by SDS-polyacrylamide gel electrophoresis as described in
Materials and Methods. The inset shows the representative poly(Glu, Tyr) phos-
phorylated bands which correspond to the bar graph. The samples were quan-
titated in triplicate, and background phosphorylation in lanes without the poly-
(Glu, Tyr) substrate was subtracted. Inhibition was measured as a percentage of
the total poly(Glu, Tyr) phosphorylation. Quercetin, 2,5-MeC, and genistein
were included at final concentrations of 296, 52, and 130 mM, respectively. The
error bar shows the standard deviation.
VOL. 70, 1996 RELEASE OF A pTP-NM COMPLEX 3063
tions contained a tyrosine kinase activity and determined that
quercetin, 2,5-MeC, and genistein each significantly inhibited
phosphorylation of a synthetic poly(Glu, Tyr) substrate (Fig.
4). Phosphorylation of the substrate in the presence of quer-
cetin, 2,5-MeC, or genistein was reduced to 13, 30, or 19% of
the control (respectively). The robust phosphorylation of in-
trinsic NM proteins (as determined by the inclusion of [g-32P]
rATP with the NM) was decreased by these inhibitors (data
not shown). Interestingly, pTP itself was not phosphorylated in
these assays. These results indicate that the mechanism of pTP
release is through phosphorylation of NM proteins and not
through phosphorylation of pTP itself and may involve a cas-
cade of kinase reactions.
The results in Fig. 5 show that rATP-dependent pTP release
from the NM is inhibited by compounds in a dose-dependent
manner. Each concentration point represents the mean of qua-
druplicate samples. pTP release was almost entirely abrogated
with each of the tyrosine kinase inhibitors. The point of half-
maximal inhibition of pTP release was at a concentration of
35 mM for quercetin, 15 mM for 2,5-MeC, and 11 mM for
genistein. The Ki of genistein reported by Teraoka et al. (57)
for rat liver NM tyrosine kinase was 10 mM, similar to the
inhibitory concentration observed here for rATP-dependent
pTP release. No inhibitory concentration data for quercetin or
2,5-MeC have been reported for NM tyrosine kinases, but the
ranges of inhibitory concentrations of these drugs reported for
other tyrosine kinases are 5 to 100 mM (for quercetin; 48, 58)
and 0.8 to 5 mM (for 2,5-MeC; 47, 50). The sigmoidal profile of
the inhibition dose curves was similar to that of typical tyrosine
kinase-dependent functions (50, 57).
The presence of a 30-kDa tyrosine kinase associated with rat
liver NM and capable of autophosphorylation has been re-
ported previously (40, 57). We have also detected a single
30-kDa band in our NM preparations by Western blotting with
an anti-phosphotyrosine MAb (data not shown), but there is
no evidence at present about this 30-kDa protein representing
the previously reported tyrosine kinase or about the role that
this tyrosine kinase might play in the release of pTP from the
NM.
Tyrosine kinase-dependent release of pTP-bound Ad DNA
termini from the NM. In order to demonstrate that this ty-
rosine kinase-dependent mechanism was relevant to a normal
Ad infection, we tested the release of Ad DNA termini from
the NM in the presence of the inhibitors (Fig. 6). The Ad DNA,
which is covalently linked to pTP upon replication, serves as an
indicator of the presence of pTP. In these experiments, NM
was prepared from Ad-infected cells at 15 h p.i., the Ad and
the chromosomal DNAs were cleaved with HindIII, and the
supernatant from after the treatment was probed for release of
the Ad DNA ends by dot blotting, with oligonucleotides spe-
cific for the right or left ends of the Ad genome being used.
Incubation of this NM preparation with 3 mM rATP released
25% of the Ad DNA ends from the NM compared with the
control lacking rATP. Quercetin, 2,5-MeC, and genistein ef-
fectively blocked release of both left and right Ad DNA ends.
In a result similar to the results shown in Fig. 1, 3 mM rAMP-
PNP caused essentially no release of the left Ad DNA end
(Fig. 6), implicating rATP hydrolysis in this process. All of
these results are consistent with the inhibition of pTP release
observed with NM prepared from vvpTP1-infected cells. The
apparent difference in the intensities of the radioactive signals
for the left and right Ad ends in the dot blot is probably due to
differences in the relative efficiencies of hybridization of the
oligonucleotides used to identify the left and right Ad ends.
To identify the maximal percentage of pTP-bound Ad DNA
releasable with rATP, we incubated Ad-NM with increasing
FIG. 5. Dose dependence of the inhibition of pTP release from the NM. Fifty micrograms of pTP-NM was incubated with 3 mM rATP and various concentrations
of tyrosine kinase inhibitor. The concentrations of the inhibitors used were as follows: quercetin, 0, 18.5, 36.9, 73.9, 147.8, and 296 mM; 2,5-MeC, 0, 20.6, 41.2, 61.8,
82.4, and 102 mM; and genistein, 0, 14.8, 29.6, 59.2, 92.5, and 129.5 mM. Supernatants were electrophoresed on 10% polyacrylamide gels containing 0.1% SDS which
were then dried to Whatman 3MM paper. Release of pTP was quantitated with a PhosphorImager (Molecular Dynamics). Quadruplicate samples were prepared for
each concentration point, and the standard deviations of the means for each dose are shown by the bars above and below the point; where no bars are shown, the
standard deviation of the mean was too small to be apparent on the scale of the graph. Inhibition was measured as a percentage of the total amount of pTP released
with rATP alone.
FIG. 6. Tyrosine kinase-dependent release of pTP-bound Ad DNA termini
from the NM. Ad-infected HeLa cell NM was incubated with 3 mM rATP and
with or without quercetin (296 mM), 2,5-MeC (52 mM), genistein (130 mM), or
AMP-PNP (3 mM) as indicated. Samples of total Ad NM (Total) are indicated.
Pellets (P) and supernatants (S) recovered after the 1-h reactions are indicated.
Duplicate samples for each condition were blotted to nitrocellulose and probed
with oligonucleotides representing the left (823-842) and right (35,683-35,702)
ends of the genome.
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concentrations of rATP. Southern blot analysis was performed
with an Ad left end- or right end-specific oligonucleotide probe
(823-842 and 35,683-35,702, respectively). Release of Ad DNA
was expressed as a percentage of the total Ad DNA in the
control sample and graphed as a function of rATP concen-
tration (Fig. 7). The resulting plot began to plateau at between
10 to 15 mM rATP, and nearly 75% of the bound Ad DNA
ends could be released at the highest concentrations; oligonu-
cleotide probes specific for left or right ends gave similar re-
sults, suggesting that either Ad end was equally able to be
released by the rATP treatment and that one Ad end was not
preferentially trapped in the NM. That 100% of the ends could
not be released may be due to the trapping of the remaining
ends inside the NM, the inefficient cutting of the Ad DNA by
HindIII, or the binding of the remaining 20% of Ad ends to
other sites in the NM that are not susceptible to release with
rATP.
A pTP-NM protein complex is capable of binding Ad origin
DNA. Ad origin-specific DNA binding activity of pTP-NM
complexes was tested to show that the pTP-NM complexes
were functional in the formation of pTP-DNA complexes. The
results of this pTP gel shift-supershift assay, originally devel-
oped to study the interactions of pTP and Ad polymerase (56),
is shown in Fig. 8. The control lanes with no protein, HeLa
cytoplasm, or NME alone did not show a gel shift. Supershift
of the pTP-specific complex with a purified pTP MAb verified
the involvement of pTP in the origin binding activity. The
origin DNA binding activity was competed with by the addition
of a 300 M excess of unlabeled dsDNA 18-bp oligonucleotide,
indicating specificity for origin binding. The addition of either
rATP NME or 8 M urea NME to the pTP gel shift reaction
also caused a significant supershift. These results indicate that
the supershifted pTP-NM complex is still capable of binding
the Ad origin. These data present the possibility that the
pTP-NM interaction may be closely involved in initiation com-
plex formation.
DISCUSSION
In uninfected cells, the NM is thought to organize sites of
cellular replication and transcription (9). The Ad genome has
also been shown to localize to the NM through an interaction
mediated by pTP (7, 49). The studies reported here focused on
understanding the mechanisms which influence the attachment
of the pTP binding sites to the NM. Previous work had sug-
gested a number of kinases that affect the integrity of the NM
(17, 39, 54, 57). We have provided evidence here that one or
more tyrosine kinase-mediated phosphorylation events may
also be an important mechanism for controlling the attachment
of at least one NM protein to which pTP binds and that this
process requires rATP hydrolysis. Further supporting the hy-
pothesis that tyrosine kinase activity controls pTP release is the
fact that the magnitude of the inhibition of poly(Glu, Tyr)
phosphorylation (Fig. 4) closely reflected the repression of
pTP release (Fig. 5) at the same concentrations of inhibitor.
The similar response of poly(Glu, Tyr) substrate phosphoryla-
tion and pTP release in the presence of inhibitors further
suggests a relationship between tyrosine kinase activity and
release of pTP binding sites.
Interestingly, there appeared to be a great difference in the
percent total pTP released from vvpTP1-infected NM (1.5%)
versus that from Ad-infected NM (26%) at 3 mM rATP. This
difference suggests that there may be different functional sites
for pTP, some of which are sensitive to release by rATP. The
quantity of pTP from a vvpTP1 infection would easily exceed
the amount of pTP produced during an Ad infection and
would most likely saturate the number of sites available for
pTP-mediated binding of Ad genomes (24). Since there is a
higher fraction of total Ad DNA ends released by rATP, this
class of binding sites may be preferred during Ad infection and
attachment of Ad DNA to the NM. Release of Ad termini
continued to increase with increasing rATP concentration (Fig.
8). These concentrations of rATP are higher than what might
be expected within the nucleus (43) and may overestimate the
actual concentration needed for release because of the ineffi-
ciency of HindIII digestion of DNA attached to the NM, the
trapping of the DNA, or the loss of some component in the
salt-stripped NM preparation.
The rATP-dependent release of a 220- to 230-kDa NM
complex that contains pTP means that the complex could be
isolated either from an NM preparation of vaccinia virus-in-
FIG. 7. The maximum pTP-bound Ad DNA released from the NM by rATP
treatment. Fifty micrograms of Ad-infected HeLa NM was incubated with 0, 2,
4, 8, 10, or 15 mM rATP for a period of 1 h. Release at each rATP concentration
was assayed in triplicate. The samples were washed twice with 2 M NaCl buffer.
Supernatants and pellets were blotted to nitrocellulose and probed with the Ad
genome right-end or left-end probe. The mean counts of right (squares) or left
(diamonds) Ad DNA termini released into the supernatant for each concentra-
tion were represented as percentages of the total counts in the control sample.
FIG. 8. A pTP-NM complex is capable of binding the Ad origin of replica-
tion. Ten micrograms of pTP extract was incubated with a dsDNA 18-mer
oligonucleotide which spans the pTP binding site on the Ad type 5 origin of
replication. The reaction mixtures were incubated for 30 min at 258C, and the
protein-DNA complexes were resolved on a 5% polyacrylamide gel containing
0.1% SDS. Control lanes contained the probe with no protein, HeLa cytoplasmic
(Cyto) extract, pTP alone, pTP with 1 ml of anti-pTP MAb, pTP with a 300 M
excess (X) of unlabeled 18-mer, or 5 mg of 8 M urea (U) NME alone. As
indicated, the experimental lanes contained pTP and 5 mg of either rATP NME
or 8 M urea NME. The pTP arrow designates the pTP-specific gel shift. The
pTP-NM arrow indicates the pTP-NM supershifted complex.
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fected cells that overexpressed pTP (Fig. 2) or could be recon-
stituted in vitro from uninfected cell NME and exogenous pTP.
The presence of the bound NM proteins did not interfere with
the ability of pTP to interact with Ad origins, a crucial require-
ment for initiation of Ad DNA replication (Fig. 3 and 8). The
Far Western blot revealed that pTP was capable of binding a
series of high-MW NM bands with sizes of between 120 to 200
kDa. It is not clear at present whether these high-MW proteins
identified by Far Western blotting represent a series of NM
proteins, either in a complex or acting as independent binding
sites, or rather represent proteolytic digestion products of one
or a few large NM proteins. Binding to these different sites on
the NM could result in different regulatory or other outcomes
for the genomes located there during the course of viral infec-
tion.
There is evidence to suggest that tyrosine kinases have a
significant role in the regulation of transcription and DNA
replication in the nucleus (19, 59). A number of tyrosine ki-
nases, such as wee and Ab1, are linked to nuclear events (59).
Serine- and threonine-phosphorylating kinases in addition to
casein kinase II are also known to be NM associated (17, 55).
It is possible that the tyrosine kinase-dependent release of
pTP-NM complexes involves a cascade of kinase activities.
This possibility is supported by experiments showing an rATP-
dependent release of lamin protein, which is not known to be
a substrate for tyrosine phosphorylation (38) (Fig. 2). It was
also possible to detect kinase activity which was reduced but
not ablated in the presence of the tyrosine kinase inhibitors. It
is possible that this activity is a normal part of the cell cycle
regulation of the NM structure and may have no direct effect
on the replication or packaging of Ad DNA during infection.
It is also not clear what the normal role of the cellular
proteins that constitute these binding sites might be within the
NM. One might imagine that they might play either a struc-
tural role (perhaps as a site for cellular DNA replication or a
means to concentrate replication factors) or an enzymatic role
(providing such required cofactors as purines or pyrimidines).
The rATP-dependent release of pTP from the NM could be a
marker for one or more steps of nuclear lamina disassembly
that are mediated by phosphorylation that occurs at the G2/M
boundary. Supporting this possibility is the evidence that
rAMP-PNP and quercetin both block nuclear lamina disassem-
bly (16, 51). In addition, quercetin and genistein, used in the
present study, are known to block the cell cycle at G2/M (41,
44, 47). These results are consistent with a tyrosine kinase-
dependent control of nuclear disassembly at G2/M. Although
there is no evidence to suggest that the tyrosine kinase-medi-
ated release of pTP from the NM plays any direct role in Ad
infection, linkage of cellular kinase activity with the viral life
cycle could be a means to control the release of replicated
genomes for packaging.
There is a growing body of evidence that cellular and viral
proteins required for transcription and replication might be
amassed at discrete sites on the NM where they are eventually
to be used (2, 5, 8, 11, 42). That these sites exist is suggested by
indirect immunofluorescence experiments that showed that Ad
replication proteins are present at punctate sites within the
nucleus (11, 24, 42), perhaps within large complexes of NM
proteins. Localized concentrations of viral factors may be crit-
ical for the occurrence of successful Ad DNA replication (32).
For example, it has been shown that the Ad replication pro-
tein, DNA-binding protein, is part of a 650-kDa, high-salt,
stable complex which contains both DNA binding and kinase
activities (45). The fact that pTP associates tightly with one or
more NM proteins implies that they might have influence on
replication complex formation. We are currently pursuing pu-
rification of the NM proteins which bind pTP.
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